AI Article Synopsis

  • Hemorrhagic transformation is a serious risk in thrombolysis for stroke patients, especially in those with over 10 cerebral microbleeds, which this study aims to predict.
  • The study analyzed CT scans and clinical data from stroke patients to develop a prediction model based on factors like hypertension and certain CT markers.
  • The validated model shows strong accuracy and can guide treatment decisions for those at risk of complications from thrombolysis.

Article Abstract

Background: Hemorrhagic transformation is one of the most serious complications in intravenous thrombolysis. Studies show that the existence of more than 10 cerebral microbleeds is strongly associated with hemorrhagic transformation. The current study attempts to develop and validate a clinical prediction model of more than 10 cerebral microbleeds.

Methods: We reviewed the computed tomography markers of cerebral small vessel diseases and the basic clinical information of acute ischemic stroke patients who were investigated using susceptibility weighted imaging from 2018 to 2021. A clinical prediction model of more than 10 cerebral microbleeds was established. Discrimination, calibration, and the net benefit of the model were assessed. Finally, a validation was conducted to evaluate the accuracy and stability of the model.

Results: The multivariate logistic regression model showed hypertension, and some computed tomography markers (leukoaraiosis, lacunar infarctions, brain atrophy) were independent risk factors of more than 10 cerebral microbleeds. These risk factors were used for establishing the clinical prediction model. The area under the receiver operating characteristic curve (AUC) was 0.894 (95% CI: 0.870-0.919); Hosmer-Lemeshow chi-squared test yielded χ = 3.946 ( = 0.862). The clinical decision cure of the model was higher than the two extreme lines. The simplified score of the model ranged from 0 to 12. The model in the internal and external validation cohort also had good discrimination (AUC 0.902, 95% CI: 0.868-0.937; AUC 0.914, 95% CI: 0.882-0.945) and calibration ( = 0.157, 0.247), and patients gained a net benefit from the model.

Conclusions: We developed and validated a simple scoring tool for acute ischemic stroke patients with more than 10 cerebral microbleeds; this tool may be beneficial for paradigm decision regarding intravenous recombinant tissue plasminogen activator therapy of acute ischemic stroke.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021829PMC
http://dx.doi.org/10.3389/fneur.2022.833952DOI Listing

Publication Analysis

Top Keywords

cerebral microbleeds
20
clinical prediction
16
prediction model
16
acute ischemic
16
ischemic stroke
16
stroke patients
12
model
9
patients cerebral
8
hemorrhagic transformation
8
model cerebral
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!